You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Medtronic
Johnson and Johnson
McKinsey
Moodys

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 8,232,294

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,232,294
Title:Amino ester derivatives, sailts thereof and methods of use
Abstract: The present invention provides amino ester compounds, salts, and pharmaceutical formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Inventor(s): Xi; Ning (Thousand Oaks, CA)
Assignee: Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN)
Application Number:12/728,153
Patent Claims:see list of patent claims

Details for Patent 8,232,294

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) 2029-03-21 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) 2029-03-21 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26   Start Trial Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) 2029-03-21 RX Orphan search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26   Start Trial Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) 2029-03-21 RX Orphan search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27   Start Trial Xi; Ning (Newbury Park, CA) Sunshine Lake Pharma Co., Ltd. (Northern Industrial Area, Songshan Lake, Dongguan, Guangdong, CN) 2029-03-21 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Harvard Business School
McKinsey
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.